We are live on ! Find out more
ANAB icon

AnaptysBio

127 hedge funds and large institutions have $749M invested in AnaptysBio in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 42 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

124% more call options, than puts

Call options by funds: $673K | Put options by funds: $300K

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

4% more funds holding

Funds holding: 122127 (+5)

4% more capital invested

Capital invested by funds: $720M → $749M (+$28.4M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0.88% less ownership

Funds ownership: 101.54%100.67% (-0.88%)

29% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 42

Holders
127
Holders Change
+5
Holders Change %
+4.1%
% of All Funds
2.22%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
15
Increased
30
Reduced
42
Closed
9
Calls
$673K
Puts
$300K
Net Calls
+$373K
Net Calls Change
+$1.05M
Name Holding Trade Value Shares
Change
Change in
Stake
IFWM
76
Institute for Wealth Management
Colorado
$322K
Barclays
77
Barclays
United Kingdom
$319K +$203K +8,004 +215%
WG
78
Winton Group
United Kingdom
$312K +$292K +11,487 New
Deutsche Bank
79
Deutsche Bank
Germany
$301K -$8.99K -354 -3%
Manulife (Manufacturers Life Insurance)
80
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$289K -$25.9K -1,022 -9%
AIG
81
American International Group
New York
$286K -$6.37K -251 -2%
IBT
82
International Biotechnology Trust
United Kingdom
$271K
HPCM
83
Hunter Perkins Capital Management
Illinois
$248K
Legal & General Group
84
Legal & General Group
United Kingdom
$235K +$89.2K +3,515 +68%
VEA
85
Virtus ETF Advisers
New York
$232K -$11.4K -450 -5%
VOYA Investment Management
86
VOYA Investment Management
Georgia
$230K
ProShare Advisors
87
ProShare Advisors
Maryland
$226K -$40.3K -1,588 -16%
T. Rowe Price Associates
88
T. Rowe Price Associates
Maryland
$221K -$3.2K -126 -2%
SEI Investments
89
SEI Investments
Pennsylvania
$212K +$199K +7,835 New
OWP
90
Old Well Partners
North Carolina
$210K
ECM
91
ExodusPoint Capital Management
New York
$206K -$662K -26,080 -77%
MIM
92
MetLife Investment Management
New Jersey
$191K -$108K -4,237 -38%
PCM
93
Pinz Capital Management
New York
$187K +$175K +6,900 New
Public Employees Retirement Association of Colorado
94
Public Employees Retirement Association of Colorado
Colorado
$169K
MLICM
95
Metropolitan Life Insurance Company (MetLife)
New York
$153K -$60.1K -2,367 -30%
BNP Paribas Financial Markets
96
BNP Paribas Financial Markets
France
$136K +$56.4K +2,222 +80%
DekaBank Deutsche Girozentrale
97
DekaBank Deutsche Girozentrale
Germany
$124K
Ohio Public Employees Retirement System (OPERS)
98
Ohio Public Employees Retirement System (OPERS)
Ohio
$105K
Lazard Asset Management
99
Lazard Asset Management
New York
$60K +$56.9K +2,242 New
Zurich Cantonal Bank
100
Zurich Cantonal Bank
Switzerland
$50K

ANAB Hedge Fund Activity: Q3 2021 in Review

127 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q3 2021, worth a combined $749M — up 3.9% from $720M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ANAB positions and 9 closed out — a net gain of 6 holders — while 30 added to existing stakes and 42 trimmed.

The largest buyer was Woodline Partners, adding an estimated $12M. The largest seller was BVF Inc, cutting an estimated $12M.

  • 127 institutional investors held AnaptysBio (ANAB) as of Q3 2021, up from 122 in Q2 2021.
  • Funds reported $749M of AnaptysBio stock for Q3 2021, up 3.9% quarter-over-quarter.
  • 15 funds opened new AnaptysBio positions in Q3 2021 and 9 closed out, a net change of +6 holders.
  • The largest AnaptysBio buyer in Q3 2021 was Woodline Partners, an estimated $12M added.
  • The largest AnaptysBio seller in Q3 2021 was BVF Inc, an estimated $12M sold.

Based on aggregated 13F filings for Q3 2021.